谷歌浏览器插件
订阅小程序
在清言上使用

Real World Outcomes of First Line (1L) Nivolumab and Ipilimumab (NIVO IPI) in Metastatic Renal Cell Carcinoma (mrcc): an Update from the International Mrcc Database Consortium (IMDC).

Journal of Clinical Oncology(2024)

引用 0|浏览3
暂无评分
关键词
283-2494-9200,261-492-199-2823-7422-11056,261-492-3532-2370-7650-2700,281-5277-5597,261-492-3532-2373,298-11050,14,47,3581,14,47,171,137
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要